Literature DB >> 8452421

Primary repair of iatrogenic thoracic esophageal perforation and Boerhaave's syndrome.

S K Ohri1, T A Liakakos, V Pathi, E R Townsend, S W Fountain.   

Abstract

Ten patients seen at our unit over a 24-month period with either iatrogenic (n = 5) or spontaneous thoracic esophageal perforations (n = 5) were retrospectively reviewed. Five patients were seen within 24 hours of onset of symptoms, and 5 were seen after 24 hours or later. There was no significant difference in the presentation or subsequent clinical course in patients seen less or more than 24 hours after the onset of symptoms. Nine patients underwent primary repair together with drainage of the mediastinum, and in 1 of these a Heller's myotomy was also performed for achalasia. One patient had a two-stage esophagogastrectomy for a benign esophageal stricture. One patient (10%) with a spontaneous perforation died 48 hours after operation and was found at postmortem examination to have an in situ carcinoma at the site of the perforation. Four patients (40%) had nonfatal complications. Fistulas developed in 3 patients (30%); in 1 of these patients a second thoracotomy and a further rib resection was required for drainage of a mediastinal abscess. An esophago-cutaneous fistula and a persistent mediastinal abscess developed in 1 patient (10%) and necessitated two further thoracotomies for effective drainage. The mean hospital stay was 38.4 +/- 25.4 days (range, 16 to 76 days). The findings of this study suggest that primary repair combined with a drainage procedure is the treatment of choice for patients with a perforated intrathoracic esophagus, including those seen more than 24 hours after the onset of symptoms.

Entities:  

Mesh:

Year:  1993        PMID: 8452421     DOI: 10.1016/0003-4975(93)90261-f

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  14 in total

1.  Spontaneous rupture of middle thoracic esophagus: thoracoscopic treatment.

Authors:  Valentino Fiscon; Giuseppe Portale; Flavio Frigo; Giovanni Migliorini; Piero L Fania
Journal:  Surg Endosc       Date:  2010-05-13       Impact factor: 4.584

2.  Pericardial sac perforation: a rare complication of neonatal nasogastric tube feeding.

Authors:  Emad El-Din Mahmoud Hanafy; Samuel D Ashebu; Niran Al Naqeeb; Harini Bopaya Nanda
Journal:  Pediatr Radiol       Date:  2006-08-09

3.  Boerhaave's syndrome: primary repair vs. esophageal resection--case reports and meta-analysis of the literature.

Authors:  Otto Kollmar; Werner Lindemann; Sven Richter; Ingo Steffen; Georg Pistorius; Martin K Schilling
Journal:  J Gastrointest Surg       Date:  2003 Sep-Oct       Impact factor: 3.452

Review 4.  Esophageal perforation: a research review of the anti-infective treatment.

Authors:  Jennifer Gregory; Jason Hecht
Journal:  Int J Clin Pharm       Date:  2018-06-28

5.  Iatrogenic oesophageal perforations: a clinical review.

Authors:  D R Lawrence; R E Moxon; S W Fountain; S K Ohri; E R Townsend
Journal:  Ann R Coll Surg Engl       Date:  1998-03       Impact factor: 1.891

Review 6.  Trans-oesophageal echocardiography (TOE): contra-indications, complications and safety of perioperative TOE.

Authors:  Neil David Hauser; Justiaan Swanevelder
Journal:  Echo Res Pract       Date:  2018-08-11

7.  Treatment of Boerhaave's Syndrome.

Authors:  Daniel Wolfson; Jamie S Barkin
Journal:  Curr Treat Options Gastroenterol       Date:  2007-02

8.  Surgical treatment of esophageal perforations: the importance of a primary repair.

Authors:  L Sulpice; M Rayar; B Laviolle; D Cunin; A Merdrignac; K Boudjema; Bernard Meunier
Journal:  Surg Today       Date:  2012-09-18       Impact factor: 2.549

9.  Esophageal perforation: principles of diagnosis and surgical management.

Authors:  Markus Huber-Lang; Doris Henne-Bruns; Bernd Schmitz; Peter Wuerl
Journal:  Surg Today       Date:  2006       Impact factor: 2.549

10.  Spontaneous Pharyngeal Perforation After Forceful Vomiting: The Difference from Classic Boerhaave's Syndrome.

Authors:  Jong-Lyel Roh; Chan Il Park
Journal:  Clin Exp Otorhinolaryngol       Date:  2008-09-30       Impact factor: 3.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.